Compounds > rosiglitazone
Page last updated: 2024-08-25

rosiglitazone and Experimental Mammary Neoplasms

rosiglitazone has been researched along with Experimental Mammary Neoplasms in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (50.00)29.6817
2010's2 (33.33)24.3611
2020's1 (16.67)2.80

Authors

AuthorsStudies
Calvo, JC; Gantov, M; Lotufo, C; Pagnotta, P; Riera, MF; Rindone, GM; Toneatto, J1
Chen, P; Cheng, WY; Huynh, H; Peña-Llopis, S; Wan, Y1
Gupta, J; Kumar, P; Tikoo, K1
Alakavuklar, M; Canda, T; Cehreli, R; Guner, G; Gurel, D; Kocdor, H; Kocdor, MA; Yilmaz, O1
Apostoli, AJ; Di Lena, MA; Gonzalez, FJ; Nicol, CJ; Peterson, NT; Reid, AL; Rubino, RE; Schneider, M; SenGupta, SK; Skelhorne-Gross, G1
Borenstein, X; Jasnis, MA; Magenta, G; Rolando, R1

Other Studies

6 other study(ies) available for rosiglitazone and Experimental Mammary Neoplasms

ArticleYear
Beige adipocytes contribute to breast cancer progression.
    Oncology reports, 2021, Volume: 45, Issue:1

    Topics: 3T3-L1 Cells; Adipocytes, Beige; Adipocytes, White; Animals; Breast Neoplasms; Cell Adhesion; Cell Differentiation; Cell Line, Tumor; Cell Movement; Culture Media, Conditioned; Disease Progression; Female; Humans; Mammary Glands, Animal; Mammary Neoplasms, Experimental; Mice; PPAR gamma; Rosiglitazone; Tumor Microenvironment

2021
Macrophage PPARγ inhibits Gpr132 to mediate the anti-tumor effects of rosiglitazone.
    eLife, 2016, 10-03, Volume: 5

    Topics: Animals; Antineoplastic Agents; Cell Cycle Proteins; Gene Knockout Techniques; Macrophages; Mammary Neoplasms, Experimental; Mice; Mice, Knockout; PPAR gamma; Receptors, G-Protein-Coupled; Rosiglitazone; Thiazolidinediones

2016
Rosiglitazone synergizes anticancer activity of cisplatin and reduces its nephrotoxicity in 7, 12-dimethyl benz{a}anthracene (DMBA) induced breast cancer rats.
    BMC cancer, 2009, Apr-08, Volume: 9

    Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Blood Urea Nitrogen; Blotting, Western; Body Weight; Cisplatin; Creatinine; Drug Synergism; Enzyme-Linked Immunosorbent Assay; Histones; Kidney; Kidney Diseases; Mammary Glands, Animal; Mammary Neoplasms, Experimental; p38 Mitogen-Activated Protein Kinases; Phosphorylation; PPAR gamma; Rats; Rats, Sprague-Dawley; Rosiglitazone; Serum Albumin; Thiazolidinediones; Tumor Burden; Tumor Necrosis Factor-alpha

2009
Chemopreventive efficacies of rosiglitazone, fenretinide and their combination against rat mammary carcinogenesis.
    Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2009, Volume: 11, Issue:4

    Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Antineoplastic Agents; Carcinogens; Drug Therapy, Combination; Enzyme-Linked Immunosorbent Assay; Estradiol; Female; Fenretinide; Hypoglycemic Agents; Insulin-Like Growth Factor I; Mammary Neoplasms, Experimental; Prolactin; Rats; Rats, Sprague-Dawley; Rosiglitazone; Thiazolidinediones

2009
Stromal adipocyte PPARγ protects against breast tumorigenesis.
    Carcinogenesis, 2012, Volume: 33, Issue:7

    Topics: Adipocytes; Animals; Base Sequence; DNA Primers; Enzyme-Linked Immunosorbent Assay; Female; Mammary Neoplasms, Experimental; Mice; Mice, Knockout; PPAR gamma; Real-Time Polymerase Chain Reaction; Rosiglitazone; Stromal Cells; Thiazolidinediones

2012
Rosiglitazone inhibits metastasis development of a murine mammary tumor cell line LMM3.
    BMC cancer, 2008, Feb-08, Volume: 8

    Topics: Administration, Oral; Anilides; Animals; Cell Adhesion; Cell Movement; Dose-Response Relationship, Drug; Lung Neoplasms; Mammary Neoplasms, Experimental; Matrix Metalloproteinases; Mice; Mice, Inbred BALB C; Neoplasm Invasiveness; Nitric Oxide; PPAR gamma; Rosiglitazone; Thiazolidinediones; Tumor Cells, Cultured

2008